A Literature Review: Active Compound Content and Pharmacological Activity of Bitter Melon Plant (Momordica charantia L.) for Health
Authors
Venya Nabila Virdausy , Faizah Erica Andi Sabrina , Akyunul JannahDOI:
10.29303/jbt.v25i1.8207Published:
2025-01-21Issue:
Vol. 25 No. 1 (2025): Januari - MaretKeywords:
Active compounds, bitter melon, Momordica charantia L., pharmacological activity, secondary metabolite.Articles
Downloads
How to Cite
Downloads
Metrics
Abstract
Bitter melon (Momordica charantia L.) is a climbing plant that has benefits for the community's medicinal system. This review article aims to explore the active compound content and pharmacological activity of the M. charantia plant in the health sector. This study employed a literature review method by gathering data from various references, including journals, books, online articles, and other forms of literature, and summarizing the findings. The bioactive compounds of this plant are triterpenoids, steroids, flavonoids, tannins, saponins, alkaloids, polyphenols and glycosides. The bioactive content in the M. charantia plant can be used in the health sector, such as antidiabetic, antibacterial, antioxidant and anticancer. Its traditional uses and modern scientific research highlight its potential as an exploitable resource. The biological effects of M. charantia extract have a direct impact on human health. The results of this review are valuable as they can guide future research on the extraction of bioactive compounds from M. charantia and their potential applications.
References
Agrawal, M., & Kamal, R. (2013). In Vitro Clonal Propagation and Phytochemical Analysis of Momordica charantia Linn. Journal of Pharmacognosy and Phytochemistry, 2(1): 66-77. ISSN: 2278- 4136.
Agustin, Tesya. (2020). Potensi Metabolit Aktif dalam Sayuran Cruciferous untuk Menghambat Pertumbuhan Sel Kanker. Jurnal Penelitian Perawat Profesional, 2(4). DOI: 10.37287/jppp.v2i4.202.
Al-Ishaq, R. K., Abotaleb, M., Kubatka, P., Kajo, K., & Busselberg, D. (2019). Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanism and Effect to Improve Blood Sugar Levels. Biomolecules, 10(2): 164. DOI: 10.3390/biom9090430.
Altuhafi, A., Altun, M., & Hadwan, M. H. (2021). The Correlation Between Selenium-Dependent Glutathione Peroxidase Activity and Oxidant/ Antioxidant Balance in Sera of Diabetic Patients with Nephropathy. Reports of Biochemistry & Molecular Biology, 10(2): 164. DOI: 10.52547/rbmb.10.2.164.
Bermawie, N., Trisilawati, O., Sukamto, Nurhayati, H., & Pitono, J. (2020). Potensi Tanaman Rempah, Obat dan Atsiri Menghadapi Masa Pandemi Covid 19. Bogor: Balai Penelitian Tanaman Rempah dan Obat. ISBN: 978-979-548-062-4
Calderon-Montano, J. M., Burgos-Moron, E., Perez-Guerrero, C., & Lopez-Lazaro, M. (2011). A Review on the Dietary Flavonoid Kaempferol. Mini Reviews in Medicinal Chemistry, 11(4): 298-344. DOI: 10.2174/138955711795305335.
Chekka, Satya., & Mantipelly, Naresh K. (2020). Momordica charantia: A Natural Medicinal Plant. GSC Biological and Pharmaceutical Sciences, 12(2): 129-135. DOI: https://doi.org/10.30574/gscbps.2020.12.2.0251.
Dam, N. P., Dien, V. M., Thanh, L., Hien, P., & Tram, N. (2019). Investigation of Antimicrobial Activity and Chemical Constituents of Momordica charantia L. Var. Abbreviata Ser. Vietnam Journal of Science and Technology, 57(2): 155-161. DOI: https://doi.org/10.15625/2525-2518/57/2/12727.
de Oliveira, M. S., da Costa, W. A., Bezerra, F. W. F., Araujo, M. E., Ferreira, G. C., & Junior, R. N. de C. (2018). Phytochemical Profile and Biological Activities of Momordica charantia L. (Cucurbitaceae): A Review. African Journal of Biotechnology, 17(27): 829-846. DOI: 10.5897/AJB2017.16374
Fang EF, Froetscher L, Scheibye-Knudsen M, Bohr VA, Wong JH, Ng TB. (2019). Emerging Antitumor Activities of the Bitter Melon (Momordica charantia). Curr Protein Pept Sci. 20(3):296-301. DOI: 10.2174/1389203719666180622095800
Fernandes, N., Lagishetty, C. V., Panda, V. S., Naik, S. R. (2007). An Experimental Evaluation of the Antidiabetic and Antilipidemic Properties of a Standardized Momordica charantia Fruit Extract. Journal: BMC Complementary and Alternative Medicine, 7: 29. DOI: 10.1186/1472-6882-7-29.
Gayathry, K. S., & John, J. A. (2022). A Comprehensive Review on Bitter Gourd (Momordica charantia L.) As a Gold Mine of Functional Bioactive Components for Therapeutic Foods. Food Production, Processing and Nutrition, 4(1): 10. DOI: https://doi.org/10.1186/s43014-022-00089-x.
Giovannini, P., Howes, M. J. R., & Edwards, S. E. (2016). Medicinal Plants Used in the Traditional Management of Diabetes and its Sequelae in Central America: A Review. Journal of Ethnopharmacology, 184:58–71. DOI: https://doi.org/10.1016/j.jep.2016.02.034.
Güneş, H., Alper, M., & Çelikoğlu, N. (2019). Anticancer Effect of the Fruit and Seed Extracts of Momordica charantia L. (Cucurbitaceae) on Human Cancer Cell Lines. Tropical Journal of Pharmaceutical Research, 18(10): 2057-2065. DOI: https://doi.org/10.4314/tjpr.v18i10.9.
Gupta, M., Sharma, S., Gautam, A. K., & Bhadauria, R. (2011). Momordica charantia Linn. (Karela): Nature’s Silent Healer. International Journal of Pharmaceutical Sciences Review and Research. 11(1): 32-37.
Han, C., Zuo, J., Wang, Q., Xu, L., Wang, Z., Dong, H., & Gao, L. (2015). Effects of 1-MCP on Postharvest Physiology and Quality of Bitter Melon (Momordica charantia L.). Scientia Horticulturae, 182: 86-91. DOI: https://doi.org/10.1016/j.scienta.2014.07.024.
Jia, S., Shen, M., Zhang, F., & Xie, J. (2017). Recent Advances in Momordica charantia: Functional Components and Biological Activities. International Journal of Molecular Sciences, 18(12): 2555. DOI: 10.3390/ijms18122555.
Joseph, B., & Jini, D. (2013). Antidiabetic Effects of Momordica charantia (Bitter Melon) and Its Medicinal Potency. Asian Pacific Journal of Tropical Diseases, 3(2): 93-102. DOI: 10.1016/S2222-1808(13)60052-3.
Kang, J., Zeng, B., Tang, S., Wang, M., Han, X., Zhou, C., & Tan, Z. (2017). Effects of Momordica charantia Polysaccharide on In Vitro Ruminal Fermentation and Cellulolytic Bacteria. Italian Journal of Animal Science, 16(2): 226-233. DOI: https://doi.org/10.1080/1828051X.2017.1289825.
Kenny, O., Smyth, T. J., Hewage, C. M., & Brunton, N. P. (2013). Antioxidant Properties and Quantitative UPLC-MS Analysis of Phenolic Compounds from Extract of Fenugreek (Trigonella foenum-graecum) Seeds and Bitter Melon (Momordica charantia) Fruit. Food Chem, 141: 4295-4302. DOI: 10.1016/j.foodchem.2013.07.016.
Ketut, D. M., Adnyana, D. P. A., Rinaldhi, C. P., Octaviani, R. R., & Cempaka, D. K. S. (2019). The Antidiabetic Effect of Bitter Melon (Momordica charantia L.) Extracts Towards Glucose Concentration, Langerhans Islets, and Leydig Cells of Hyperglycemic Mice (Rattus norvegicus). EurAsian Journal of BioSciences, 13(2): 757-762.
Kim, H. Y., Mok, S. Y., Kwon, S. H., Lee, D. G., Cho, E. J., & Lee, S. (2013). Phytochemical Constituents of Bitter Melon (Momordica charantia). Natural Product Sciences, 19(4): 286-289. DOI: 10.3390/ijms18122555.
Kim, S. K., Jung, J., Jung, J. H., Yoon, N., Kang, S. S., Roh, G. S., & Hahm, J. R. (2020). Hypoglycemic Efficacy and Safety of Momordica charantia (Bitter Melon) in Patients with Type 2 Diabetes Mellitus. Complement Ther Med, 52: 102524. DOI: 10.1016/j.ctim.2020.102524.
Liu, X., Chen, T., Hu, Y., Li, K., & Yan, L. (2014). Catalytic Synthesis and Antioxidant Activity of Sulfated Polysaccharide from Momordica charantia L. Biopolymers, 101(3): 210-215. DOI: http://dx.doi.org/10.1002/bip.22312.
Liu, P., Lu, J. F., Kang, L. P., Yu, H. S., Zhang, L. J., Song, X. B., & Ma, B. P. (2012). A New C30 Sterol Glycoside from the Fresh Fruits of Momordica charantia. Chinese Journal of Natural Medicines, 2(10): 88-91. DOI: https://doi.org/10.3724/SP.J.1009.2012.00088.
Lu, Y. L., Liu, Y. H., Liang, W. L., Chuang, J. H., Cheng, K. T., & Liang, H. J. (2011). Antibacterial and Cytotoxic Activities of Different Wild Bitter Gourd Cultivars (Momordica charantia l. var. abbreviata seringe). Bot. Stud., 52: 427–434.
Mahmoud, M. F., Hassan, N. A., El Bassossy, H. M., & Fahmy., A. (2013). Quercetin Protect Against Diabetes-Induced Exaggerated Vasocon-Striction in Rats: Effect on Low Grade Inflammation. PLoS ONE, 8(5): e63784. DOI: 10.1371/journal.pone.0063784.
Mahwish., Saeed, F., Sultan, M.T., Riaz, A., Ahmed, S., Bigiu, N., Amarowicz, R., & Manea, R. (2021). Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment. Plants, 10: 730. DOI: 10.3390/plants10040730.
Majid, Abdul., Palestin, Bondan., Ekwantini, Rosa D., & Prayogi, Agussarwo. (2020). Influence of Prodiabetic Bitter Melon Syrup Against Blood Glucose Levels. PJMHS, 14(2). pp. 11454-1456. ISSN 1996-7195
Masithoh, D. A., Kusdarwati, R., & Handijatno, D. (2019). Antibacterial Activity of Bitter Gourd (Momordica charantia L.) Leaf Extract Against Aeromonas hydrophila. IOP Conf. Series: Earth and Environmental Science, 236: 012096. DOI: 10.1088/1755-1315/236/1/012096.
Matsuda, M., & de Fronzo, R. A. (1999). Insulin Sensitivity Indices Obtained from Oral Glucose Tolerance Testing: Comparison with the Euglycemic Insulin Clamp. Diabetes Care, 22: 1462–1470. DOI: 10.2337/diacare.22.9.1462.
Muribeca, A. de J. B., Gomes, P. W. P., Paes, S. S., de Costa, A. P. A., Gomes, P. W. P., Viana, J. de S., Reis, J. D. E., Pamplona, S. das G. S., Silva, C., Bauermeister, A., Santos, L. de S., & de Silva, M. N. (2022). Antibacterical Activity from Momordica charantia L. Leaves and Flavones Enriched Phase. Pharmaceutics, 14(9): 1796. DOI: 10.3390/pharmaceutics14091796.
Nagarani, G., Abirami, A., & Siddhuraju, P. (2014). A Comparative Study on Antioxidant Potentials, Inhibitory Activities Against Key Enzymes Related to Metabolic Syndrome, and Anti-inflammatory Activity of Leaf Extract from Different Momordica Species. Food Sci. Human Wellness, 3(1): 36-46. DOI: https://doi.org/10.1016/j.fshw.2014.02.003.
Nirnadia, Kamilla, L., & Djohan, H. (2020). Potensi Pare (Momordica charantia Linn) sebagai Antidiabetes. Jurnal Laboratorium Khatulistiwa, 4(1): 34-39. DOI: https://doi.org/10.30602/jlk.v4i1.942.
Oktavia GAE, Arifah FH, Arifa N, Sujarwo W. (2020). Pengetahuan etnomedisin masyarakat bali tentang pare (Momordica charantia L.; Cucurbitaceae): Sebuah kajian kepustakaan. Buletin Kebun Raya 23(3): 179‒186. DOI: https://doi.org/10.14203/bkr.v23i3.644
Parawansah, Nuaralifah, & Yulfa. (2022). Fraksi Etanol Buah Pare (Momordica charantia L.) sebagai Antiinflamasi Terhadap Kadar Tumor Necrosis Factor Alpha (TNF-α). Journal Syifa Science and Clinical Research, 4(1): 10-17. DOI: https://doi.org/10.37311/jsscr.v4i1.13484.
Putri, D. F. A., Putra, H., & Adekayanti, P. (2023). Studi Potensi Daun Pare Hutan (Momordica balsamina Linn.) sebagai Natural Anthelmintic. Jurnal Kesehatan Tambusai, 4(3): 4027-4031. DOI: https://doi.org/10.31004/jkt.v4i3.17139.
Qian, S., Sun, L., Li, J., Wu, J., Hu, G., Han, Y., Yu, K., & Zhang, S. (2016). MAP30 Inhibits Autophagy Through Enhancing Acetyltransferase p300 and Induces Apoptosis in Acute Myeloid Leukemia Cells. Oncol. Rep., 35: 3705–3713.
Rahmadani, Salasa, A. M., & Rachmawaty, D. (2023). Aktivitas Antibakteri Ekstrak Etanol Biji Pare (Momordica charantia L.) Terhadap Staphylococcus aureus dan Pseudomonas aeruginosa. An-Najat: Jurnal Ilmu Farmasi dan Kesehatan, 1(2): 235-242. DOI: 10.3892/or.2016.4705.
Rahmatullah, W., & Sari, A. D. L. (2021). Potensi Ekstrak Daun Pare (Momordica charantia L.) sebagai Alternatif Meningkatkan Kualitas Hidup Penderita Hepatitis B. Media Ilmu Kesehatan, 10(1): 77-86. DOI: https://doi.org/10.30989/mik.v10i1.526.
Ranasinghe, K. N. K., Premarathna, A. D., Mahakapuge, T. A. N., Wijesunder, K. K., Ambagaspitiya, A. T., Jayasooriya, A. P., Kularatne, S. A. M., & Rajapakse, R. P. V. J. (2021). In Vivo Anticancer Effects of Momordica charantia Seed Fat on Hepatocellular Carcinoma in a Rat Model. Journal of Ayurveda and Integrative Medicine, 12: 435-442. DOI: 10.1016/j.jaim.2021.03.001.
Rasmi, D. A. C., Zulkifli, L., & Ahadia, N. (2023). Antimicrobial Activity Test of Bitter Melon (Momordica charantia L.) Plant Extract Against Staphylococcus epidermidis, Escherichia coli Bacteria and Candida albicans. Jurnal Penelitian Pendidikan IPA, 9(2): 454–458. DOI: https://doi.org/10.29303/jppipa.v9i2.3699.
Richter, E., Geetha, T., Burnett, D., Broderick, T. M., & Babu, J. R. (2023). The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer’s Disease. International Journal of Molecular Sciences, 24(5): 4643. DOI: 10.3390/ijms24054643.
Saeed, F., Afzaal, M., Niaz, B., Arshad, M. U., Tufail, T., Hussain, M. B., & Javed, A. (2018). Bitter Melon (Momordica charantia): A Natural Healthy Vegetable. International Journal of Food Properties, 21(1): 1270-1290. DOI: https://doi.org/10.1080/10942912.2018.1446023.
Sathishsekar, D, & Subramanian, S. (2005). Antioxidant Properties of Momordica charantia (Bitter Gourd) Seeds on Streptozotocin Induced Diabetic Rats. Asia Pacific Journal of Clinical Nutrition, 14(2): 153-8. PMID: 15927932.
Sriwijayanti, Apriningtias, Situmeang, B., Yulianti, N., Susvira, D., & Widiyanto, H. (2024). Skrining Fitokimia dan Aktivitas Antioksidan ekstrak Metanol Biji Buah Pare (Momordica charantia L.). Jurnal βeta Kimia, 4(1): 77-84. DOI: https://doi.org/10.35508/jbk.v4i1.15487.
Taupik, M., Djuwarno, E. N., & Mustapa, M. A. (2021). Kajian Fitokimia dan Identifikasi Senyawa Metabolit Sekunder Daun Pare (Momordica charantia L.). Al-Kimia, 9(2): 170-181. DOI: https://doi.org/10.24252/al-kimia.v9i2.23633.
Wang, Q., Wu, X., Shi, F., & Liu, Y. (2019). Comparison of Antidiabetic Effects of Saponins and Polysaccharides from Momordica charantia L. in STZ-Induced Type 2 Diabetic Mice. Biomedicine & Pharmacotherapy, 109: 744-750. DOI: 10.1016/j.biopha.2018.09.098.
Wowor, K. B., Bodhi, W., Datu, O. S., & Windah, A. L. L. (2022). Uji Aktivitas Antidiabetes Ekstrak Buah Pare sebagai Inhibitor Enzim α-Glukosidase secara In Silico. Pharmacon, 11(4): 1754-1762. https://doi.org/10.35799/pha.11.2022.42035.
Xia, S. F., Xie, Z. X., Qiao, Y., Li, L. R., Cheng, X. R., Tang, X., Shi, Y. H., & Le, G. W. (2015). Differential Effect of Quercetin on Hippocampus-Dependent Learning and Memory in Mice Fed with Different Diets Related with Oxidative Stress. Physiology & Behavior, 138: 325-331. DOI: 10.1016/j.physbeh.2014.09.008.
Xu, J., Cao, K., Li, Y., Zou, X., Chen, C., Szeto, I. M. Y., & Dong, Z. (2014). Bitter Gourd Inhibits the Development of Obesity-Associated Fatty Liver in C57BL/6 Mice Fed a High-Fat Diet. The Journal of Nutrition. 144(4): 475-483. DOI: 10.3945/jn.113.187450.
Xu, B., Li, Z., Zeng, T., Zhan, J., Wang, S., Ho, C. -T, & Li, S. (2022). Bioactive of Momordica charantia as Potential Anti-Diabetic/ Hypoglycemic Agents. Molecules, 27: 2175. DOI: 10.3390/molecules27072175.
Yoshime, L. T., de Melo, I. L. P., Sattler, J. A. G., de Carvalho, E. B. T., & Mancini-Filho, J. (2016). Bitter Gourd (Momordica charantia L.) Seed Oil as a Naturally Rich Source of Bioactive Compounds for Nutraceutical Purposes. Nutrire, 41: 1-7. DOI: http://dx.doi.org/10.1186/s41110-016-0013-y.
Zhan, K., Ji, X., & Luo, L. (2023). Recent Progress in Research on Momordica charantia Polysaccharides: Extraction, Purification, Structural Characteristics and Bioactivities. Chemical and Biological Technologies in Agriculture, 10(1): 58. DOI: http://dx.doi.org/10.1186/s40538-023-00433-4.
License
Copyright (c) 2025 Venya Nabila Virdausy, Faizah Erica Andi Sabrina, Akyunul Jannah

This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.